Albumin solutions--their production and quality control

Area of Science:

• Pharmacovigilance
• Clinical Chemistry
• Medical Device Safety

Background:

• Hypotension syndrome is the predominant side effect associated with albumin solution infusions.
• Clinical reactions reported to CSL over the past decade consistently identify hypotension as a major concern.
• Previous efforts focused on reducing PKA contamination in SPPS to mitigate adverse events.

Purpose of the Study:

• To analyze clinical reactions to albumin solutions over the last decade.
• To investigate the persistent occurrence of hypotension syndrome despite PKA reduction.
• To identify alternative causes for hypotensive effects during or after albumin infusion.

Main Methods:

• Comprehensive analysis of clinical complaints reported to CSL.
• Review of adverse event data spanning the past ten years.
• Correlation analysis between PKA levels and reported hypotension incidents.

Main Results:

• Hypotension syndrome remains the most frequent clinical reaction to albumin solutions.
• The incidence of reported reactions is approximately 1 in 20,000 bottles.
• Elimination of PKA from SPPS has not led to a reduction in reported adverse clinical events.

Conclusions:

• Factors other than PKA contamination are responsible for hypotension syndrome during albumin infusion.
• Further investigation into alternative etiological factors for hypotensive effects is warranted.
• The study highlights the need to explore other potential causes of adverse reactions to albumin solutions.